DALIRESP®(roflumilast)is indicated as a treatment to reduce the risk of chronic obstructive pulmonary disease (COPD) exacerbations in patients with severe COPD associated with chronic bronchitis and a history
Non-invasive ventilation has been used as a palliative treatment to reduce dyspnoea. Hypoxaemic COPD patients, on long-term oxygen therapy, may show reduced health-related quality of life, cognitive function, and depression. Only a small proportion of patients with severe COPD discuss end-of-...
This retrospective survey relied on the 12-month recall of patients for COPD-related hospitalizations, ED visits, primary care consultations, treatment and laboratory tests.23 Costs were derived by multiplying the unit cost of a resource by the frequency of the resource use in currency of the ...
117 patients were screened and 60 COPD patients entered a 1-month run-in period on low-dose ICS/LABA budesonide/formoterol (BUD/F) 200/6 one inhalation b.i.d. Patients were then randomly assigned to 3-month treatment with either a high dose BDP/F 100/6 two inhalations b.i.d. (n ...
Your Treatment Choices for Moderate-to-Severe COPD Medically Reviewed by Carol DerSarkissian, MD on April 27, 2023 Written by WebMD Editorial Contributors Medications Oxygen Therapy Surgery Pulmonary Rehabilitation 4 min read Even though there's no cure for chronic obstructive pulmonary disease (CO...
Severity criteria for exacerbations of chronic obstructive pulmonary disease (COPD) have not yet been defined as they have for pneumonia. Therefore, investigators have usually adopted pragmatic criteria to define their study populations according to the subject of the study. For example, studies addressi...
In parallel, asthma management guidelines evolved to incorporate the earlier introduction of anti-inflamma- tory therapy to treatment regimes in a step-wise [6, 7] manner within this paradigm. In the past, patients with persisting poor control, despite good adherence to maximal doses of ICS ...
Conclusions The combination therapy with salmeterol / fluticasone propionate and tiotropium was superior to salmeterol / fluticasone propionate in treatment of sever to very severe stable COPD patients in improving lung function, exercise tolerance, and quality of life, without additional adverse effects. ...
Serum desmosine is higher in patients with AATD-COPD compared with usual COPD.43 Equally, administration of pooled human AAT has been shown to reduce serum levels of desmosine44 and has been suggested as a possible treatment for atherosclerosis in the context of myocardial i...
However, this definition is not universally accepted, contributing to difficulties in developing treatment guidelines.1 Naming conventions for "long COVID" also vary and include post-acute SARS-CoV2 COVID (PASC), post-COVID syndrome, long COVID, and others.1,2 Further, the condition appears ...